Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Panelius
A Salmi

Showing results (151-160 of 341) with videos related to

Pageof 35
Sort By:
Neuroscience Letters|June 16, 2004
IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitisEeva K Broberg, Aimo A Salmi, Veijo Hukkanen
FEMS Immunology and Medical Microbiology|January 1, 1993
Antibody and T cell responses to measles virus polypeptides and synthetic peptidesM J Mäkelä, J Ilonen, A A Salmi
Minerva Medica|December 15, 1986
[Intrahepatic presinusoidal portal hypertension in a female patient with chronic lymphatic leukemia]A Salmi, A Paroli, G Ghizzoni, et al.
Recenti Progressi in Medicina|May 1, 1987
[Diagnostic value of serum ferritin in primary carcinoma of the liver associated with cirrhosis]A Salmi, G Rangoni, G Pizzocolo, et al.
The Journal of General Virology|July 28, 1999
Characterization of T cell epitopes in measles virus nucleoproteinJ Marttila, J Ilonen, E Norrby, et al.
Journal of Medical Virology|January 1, 1979
OC43 strain-related coronavirus antibodies in different age groupsT Hovi, H Kainulainen, B Ziola, et al.
Annales Medicinae Experimentalis Et Biologiae Fenniae|January 1, 1973
Absorption of radiovitamin B12 in mice after specific irradiation of the stomachH A Salmi, T T Salmi, I Lindgren
Scandinavian Journal of Infectious Diseases|January 1, 1970
Age-specific attack rate in females during a rubella epidemicA Salmi, P Halonen, K Kouvalainen, et al.
Acta Neurologica Scandinavica|June 1, 1982
Antibodies to nuclear and smooth muscle antigens in multiple sclerosis and control patientsT Hyypiä, M Viander, M Reunanen, et al.
Acta Neurologica Scandinavica|July 1, 1983
Lymphocyte blast transformation responses to mitogens and specific antigens in different clinical phases of multiple sclerosis: a follow-up studyJ Ilonen, M Reunanen, A Salmi, et al.
Pageof 35

Showing results (151-160 of 341) with videos related to

Sort By:
Pageof 35
Neuroscience Letters|June 16, 2004
IL-4 is the key regulator in herpes simplex virus-based gene therapy of BALB/c experimental autoimmune encephalomyelitisEeva K Broberg, Aimo A Salmi, Veijo Hukkanen
FEMS Immunology and Medical Microbiology|January 1, 1993
Antibody and T cell responses to measles virus polypeptides and synthetic peptidesM J Mäkelä, J Ilonen, A A Salmi
Minerva Medica|December 15, 1986
[Intrahepatic presinusoidal portal hypertension in a female patient with chronic lymphatic leukemia]A Salmi, A Paroli, G Ghizzoni, et al.
Recenti Progressi in Medicina|May 1, 1987
[Diagnostic value of serum ferritin in primary carcinoma of the liver associated with cirrhosis]A Salmi, G Rangoni, G Pizzocolo, et al.
The Journal of General Virology|July 28, 1999
Characterization of T cell epitopes in measles virus nucleoproteinJ Marttila, J Ilonen, E Norrby, et al.
Journal of Medical Virology|January 1, 1979
OC43 strain-related coronavirus antibodies in different age groupsT Hovi, H Kainulainen, B Ziola, et al.
Annales Medicinae Experimentalis Et Biologiae Fenniae|January 1, 1973
Absorption of radiovitamin B12 in mice after specific irradiation of the stomachH A Salmi, T T Salmi, I Lindgren
Scandinavian Journal of Infectious Diseases|January 1, 1970
Age-specific attack rate in females during a rubella epidemicA Salmi, P Halonen, K Kouvalainen, et al.
Acta Neurologica Scandinavica|June 1, 1982
Antibodies to nuclear and smooth muscle antigens in multiple sclerosis and control patientsT Hyypiä, M Viander, M Reunanen, et al.
Acta Neurologica Scandinavica|July 1, 1983
Lymphocyte blast transformation responses to mitogens and specific antigens in different clinical phases of multiple sclerosis: a follow-up studyJ Ilonen, M Reunanen, A Salmi, et al.
Pageof 35